$EYEN
EYENOVIA, INC.

2022 Q3 Form 10-Q Financial Statement

#000141057822002278 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Gross Profit Margin
Selling, General & Admin $3.353M $3.535M $3.475M
YoY Change 37.71% 53.85% 51.09%
% of Gross Profit
Research & Development $3.877M $3.587M $3.713M
YoY Change 11.72% -2.65% -14.11%
% of Gross Profit
Depreciation & Amortization $83.00K $70.47K $75.43K
YoY Change 13.68% 55.77% 126.65%
% of Gross Profit
Operating Expenses $7.230M $7.121M $7.188M
YoY Change 22.44% 19.05% 9.46%
Operating Profit -$7.230M -$7.121M -$7.188M
YoY Change 22.44% 48.92% 33.93%
Interest Expense $177.1K $153.4K $145.2K
YoY Change 48.59% 96.59% 2721.23%
% of Operating Profit
Other Income/Expense, Net $70.28K $33.38K -$7.073K
YoY Change -977.37% 79.77% -138.06%
Pretax Income -$7.309M -$7.239M -$7.340M
YoY Change 31.25% 49.52% 37.19%
Income Tax
% Of Pretax Income
Net Earnings -$7.309M -$7.239M -$7.340M
YoY Change 31.25% 49.52% 37.15%
Net Earnings / Revenue
Basic Earnings Per Share -$0.21 -$0.22 -$0.24
Diluted Earnings Per Share -$0.21 -$0.22 -$0.24
COMMON SHARES
Basic Shares Outstanding 34.21M 33.64M 30.01M
Diluted Shares Outstanding 34.63M 33.64M 30.01M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.40M $21.51M $26.72M
YoY Change 28.87% -20.86% 7.25%
Cash & Equivalents $17.40M $21.50M $26.70M
Short-Term Investments
Other Short-Term Assets $10.59M $2.842M $1.830M
YoY Change 21.69% 147.79% -5.66%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.42M $25.61M $30.40M
YoY Change 25.4% -13.16% 8.45%
LONG-TERM ASSETS
Property, Plant & Equipment $1.343M $1.407M $1.370M
YoY Change -4.99% 45.18% 93.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $200.2K $201.4K $119.0K
YoY Change
Other Assets $645.7K $8.587M $8.419M
YoY Change 442.41% 7113.25% 6915.89%
Total Long-Term Assets $1.988M $9.993M $9.789M
YoY Change 29.77% 818.57% 1093.83%
TOTAL ASSETS
Total Short-Term Assets $29.42M $25.61M $30.40M
Total Long-Term Assets $1.988M $9.993M $9.789M
Total Assets $31.41M $35.61M $40.19M
YoY Change 25.66% 16.42% 39.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.105M $2.687M $1.535M
YoY Change -34.41% 61.11% -15.67%
Accrued Expenses $2.564M $1.773M $1.057M
YoY Change 52.06% -5.03% -38.89%
Deferred Revenue
YoY Change
Short-Term Debt $7.229M $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $7.429M $7.740M
YoY Change 674.06% 892.32%
Total Short-Term Liabilities $11.02M $11.98M $10.38M
YoY Change -46.83% -17.71% -36.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $60.54K $13.53K $15.08K
YoY Change 132.31% -64.04% -62.3%
Total Long-Term Liabilities $60.54K $13.53K $15.08K
YoY Change 132.31% -99.81% -95.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.02M $11.98M $10.38M
Total Long-Term Liabilities $60.54K $13.53K $15.08K
Total Liabilities $11.08M $12.00M $10.39M
YoY Change -46.61% -44.45% -37.8%
SHAREHOLDERS EQUITY
Retained Earnings -$112.1M -$104.8M -$97.60M
YoY Change 20.28% 19.59%
Common Stock $3.553K $3.363K $3.171K
YoY Change 36.81% 29.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.33M $23.61M $29.79M
YoY Change
Total Liabilities & Shareholders Equity $31.41M $35.61M $40.19M
YoY Change 25.66% 16.42% 39.3%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.309M -$7.239M -$7.340M
YoY Change 31.25% 49.52% 37.15%
Depreciation, Depletion And Amortization $83.00K $70.47K $75.43K
YoY Change 13.68% 55.77% 126.65%
Cash From Operating Activities -$6.817M -$4.699M -$8.200M
YoY Change 33.81% -11.89% 78.26%
INVESTING ACTIVITIES
Capital Expenditures -$228.0K -$106.8K $174.6K
YoY Change -55.92% -65.31% -49.3%
Acquisitions
YoY Change
Other Investing Activities $64.71K -$85.20K -$33.10K
YoY Change
Cash From Investing Activities -$163.3K -$192.0K -$207.7K
YoY Change -68.43% -37.62% -39.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.872M -318.5K 15.65M
YoY Change -1619.93% -104.03% 976.55%
NET CHANGE
Cash From Operating Activities -6.817M -4.699M -8.200M
Cash From Investing Activities -163.3K -192.0K -207.7K
Cash From Financing Activities 2.872M -318.5K 15.65M
Net Change In Cash -4.108M -5.210M 7.254M
YoY Change -29.18% -330.01% -309.38%
FREE CASH FLOW
Cash From Operating Activities -$6.817M -$4.699M -$8.200M
Capital Expenditures -$228.0K -$106.8K $174.6K
Free Cash Flow -$6.589M -$4.592M -$8.375M
YoY Change 43.95% -8.62% 69.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33644867
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25927303
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31836582
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25630572
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Central Index Key
EntityCentralIndexKey
0001682639
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33623053
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28426616
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38365
dei Entity Registrant Name
EntityRegistrantName
EYENOVIA, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1178401
dei Entity Address Address Line1
EntityAddressAddressLine1
295 Madison Avenue, Suite 2400
dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
917
dei Local Phone Number
LocalPhoneNumber
289-1117
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 Par Value
dei Trading Symbol
TradingSymbol
EYEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34212862
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21506582
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19461850
CY2022Q2 eyen Deferred Clinical Supply Costs
DeferredClinicalSupplyCosts
1538380
CY2022Q2 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
709234
CY2021Q4 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
1805065
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1858530
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
721438
CY2022Q2 us-gaap Assets Current
AssetsCurrent
25612726
CY2021Q4 us-gaap Assets Current
AssetsCurrent
21988353
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7875000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7875000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1406666
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1271225
CY2022Q2 eyen Security Deposits
SecurityDeposits
201407
CY2021Q4 eyen Security Deposits
SecurityDeposits
132539
CY2022Q2 eyen Equipment Deposits
EquipmentDeposits
510239
CY2021Q4 eyen Equipment Deposits
EquipmentDeposits
391941
CY2022Q2 us-gaap Assets
Assets
35606038
CY2021Q4 us-gaap Assets
Assets
31659058
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2686794
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1614104
CY2022Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1014084
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1543618
CY2022Q2 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
824302
CY2021Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
845719
CY2022Q2 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
27462
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
18685
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7429131
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7150368
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11981773
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11172494
CY2022Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
13528
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
19949
CY2022Q2 us-gaap Liabilities
Liabilities
11995301
CY2021Q4 us-gaap Liabilities
Liabilities
11192443
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33623053
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28426616
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
3363
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2844
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
128405445
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110683077
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104798071
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90219306
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23610737
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20466615
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35606038
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31659058
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000000
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
800000
us-gaap Cost Of Revenue
CostOfRevenue
0
us-gaap Cost Of Revenue
CostOfRevenue
1600000
CY2022Q2 us-gaap Gross Profit
GrossProfit
0
CY2021Q2 us-gaap Gross Profit
GrossProfit
1200000
us-gaap Gross Profit
GrossProfit
0
us-gaap Gross Profit
GrossProfit
2400000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3586866
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3684647
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7299450
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8007296
CY2021Q1 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1530990
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656913
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5351667
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
12140121
CY2021Q2 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
573001
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
130090
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
351390
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3534590
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2297492
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7009555
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4541482
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7121456
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
5982139
us-gaap Operating Expenses
OperatingExpenses
14309005
us-gaap Operating Expenses
OperatingExpenses
12548778
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7121456
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4782139
us-gaap Operating Income Loss
OperatingIncomeLoss
-14309005
us-gaap Operating Income Loss
OperatingIncomeLoss
-10148778
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33376
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18566
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26303
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
37152
CY2022Q2 us-gaap Interest Expense
InterestExpense
153436
CY2021Q2 us-gaap Interest Expense
InterestExpense
78047
us-gaap Interest Expense
InterestExpense
298673
us-gaap Interest Expense
InterestExpense
83195
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2416
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
220
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2610
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1754
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7239100
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4841400
us-gaap Net Income Loss
NetIncomeLoss
-14578765
us-gaap Net Income Loss
NetIncomeLoss
-10193067
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33644867
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25927303
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31836582
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25630572
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20466615
CY2022Q1 eyen Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
14897908
CY2022Q1 eyen Stock Issued At Market Offering During Period Value New Issues
StockIssuedAtMarketOfferingDuringPeriodValueNewIssues
860365
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
908987
CY2022Q1 eyen Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7339665
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
29794210
CY2022Q2 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
18701
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1036926
CY2022Q2 eyen Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7239100
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23610737
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15303885
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
637355
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4841400
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
8990557
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
354539
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3149
us-gaap Net Income Loss
NetIncomeLoss
-14578765
us-gaap Net Income Loss
NetIncomeLoss
-10193067
us-gaap Share Based Compensation
ShareBasedCompensation
1945913
us-gaap Share Based Compensation
ShareBasedCompensation
1294268
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
145901
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75243
eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
52431
eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
15514
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
461761
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
259996
eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
-1095831
eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
-2066707
eyen Increase Decrease In Deferred Clinical Supply Costs
IncreaseDecreaseInDeferredClinicalSupplyCosts
1538380
eyen Increase Decrease In Deferred Clinical Supply Costs
IncreaseDecreaseInDeferredClinicalSupplyCosts
0
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-1600000
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-68868
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1072690
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
205969
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-529534
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-280006
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-21417
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-425769
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4000000
eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
2356
eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-2004
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12883603
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9903141
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
281342
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
647744
eyen Vendor Deposits For Property Plant And Equipment
VendorDepositsForPropertyPlantAndEquipment
118298
eyen Vendor Deposits For Property Plant And Equipment
VendorDepositsForPropertyPlantAndEquipment
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-399640
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-647744
eyen Proceeds From Sale Of Common Stock And Warrants In Registered Direct Offering
ProceedsFromSaleOfCommonStockAndWarrantsInRegisteredDirectOffering
14981299
eyen Proceeds From Sale Of Common Stock And Warrants In Registered Direct Offering
ProceedsFromSaleOfCommonStockAndWarrantsInRegisteredDirectOffering
2103991
eyen Proceeds From Issuance Of Common Stock At Market Offering
ProceedsFromIssuanceOfCommonStockAtMarketOffering
860365
eyen Proceeds From Issuance Of Common Stock At Market Offering
ProceedsFromIssuanceOfCommonStockAtMarketOffering
0
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18701
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
7500000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
448999
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
311563
eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
83391
eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
66618
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021Q4 eyen Prepaid Professional Fees
PrepaidProfessionalFees
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
130090
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15327975
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9355900
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2044732
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1194985
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27336850
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28371828
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29381582
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27176843
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21506582
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27176843
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7875000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29381582
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27176843
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
199367
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
70457
eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
675331
eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
705360
eyen Issuance Of Stock Warrants
IssuanceOfStockWarrants
351390
eyen Issuance Of Common Stock Related To Vested Restricted Stock Units
IssuanceOfCommonStockRelatedToVestedRestrictedStockUnits
7
eyen Percentage Of Success Rate Of Optejet
PercentageOfSuccessRateOfOptejet
0.98
eyen Percentage Of Successful Rate Of Traditional Eye Drops
PercentageOfSuccessfulRateOfTraditionalEyeDrops
0.50
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21500000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104800000
us-gaap Net Income Loss
NetIncomeLoss
-14600000
us-gaap Net Income Loss
NetIncomeLoss
-10200000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12900000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9900000
CY2022Q2 us-gaap Other Assets
OtherAssets
27970
CY2021Q4 us-gaap Other Assets
OtherAssets
4525
CY2022Q2 eyen Prepaid Security Deposits
PrepaidSecurityDeposits
18750
CY2021Q4 eyen Prepaid Security Deposits
PrepaidSecurityDeposits
18750
CY2022Q2 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
0
CY2021Q4 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
66250
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1858530
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7875000
CY2022Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
21256582
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
19211850
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11125705
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5436008
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
721438
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42407
CY2021Q4 eyen Accrued Franchise Tax
AccruedFranchiseTax
1680
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18799
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</p>
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
724504
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
171370
CY2022Q2 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
555166
CY2021Q4 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
343785
CY2022Q2 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
249550
CY2021Q4 eyen Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
0
CY2022Q2 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
116870
CY2021Q4 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
71375
CY2022Q2 eyen Prepaid Patent Expense
PrepaidPatentExpense
63190
CY2021Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
32797
CY2022Q2 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
52530
CY2021Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
12586
CY2022Q2 eyen Prepaid Professional Fees
PrepaidProfessionalFees
50000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
55319
eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice
3.37
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
6963
eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
3.59
CY2022Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
661423
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1245795
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
352661
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
297823
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1014084
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1543618
CY2022Q2 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
357316
CY2021Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
436840
CY2022Q2 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
225000
CY2021Q4 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
250000
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
144531
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
94792
CY2022Q2 eyen Credit Card Payable
CreditCardPayable
46700
CY2021Q4 eyen Credit Card Payable
CreditCardPayable
20000
CY2022Q2 eyen Accrued Franchise Tax
AccruedFranchiseTax
26200
CY2022Q2 eyen Accrued Travel And Entertainment Expenses Current
AccruedTravelAndEntertainmentExpensesCurrent
5756
CY2021Q4 eyen Accrued Travel And Entertainment Expenses Current
AccruedTravelAndEntertainmentExpensesCurrent
0
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
824302
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
845719
CY2022Q2 us-gaap Notes Payable
NotesPayable
7726333
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
297202
CY2022Q2 eyen Notes Payable Net Of Debt Discount Total
NotesPayableNetOfDebtDiscountTotal
7429131
CY2021Q4 us-gaap Notes Payable
NotesPayable
7500000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
349632
CY2021Q4 eyen Notes Payable Net Of Debt Discount Total
NotesPayableNetOfDebtDiscountTotal
7150368
CY2022Q1 us-gaap Supplemental Unemployment Benefits Salary Continuation
SupplementalUnemploymentBenefitsSalaryContinuation
1517000
CY2022Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-09-23
CY2022Q2 eyen Additional Number Of Months In Which Option To Extend Lease
AdditionalNumberOfMonthsInWhichOptionToExtendLease
P60M
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1036926
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
637355
us-gaap Share Based Compensation
ShareBasedCompensation
1945913
us-gaap Share Based Compensation
ShareBasedCompensation
1294268
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41778
CY2021Q4 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice
3.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
131614
eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
1.99
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
111110
CY2022Q2 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice
1.80
eyen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Rs Us Undelivered Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedRSUsUndeliveredNumber
67408
eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested Rs Us Undelivered Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedRSUsUndeliveredWeightedAverageExercisePrice
3.70
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.88
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.93
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4926750
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2022Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
3275927
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4605289
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
133982
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
110841
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1217715
CY2021Q4 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.69
eyen Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
6740260
eyen Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
2.56
eyen Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
1870130
eyen Class Of Warrant Or Right Exercised Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice
0.01
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6087845
CY2022Q2 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
3.37
eyen Class Of Warrant Or Right Outstanding Weighted Average Remaining Life
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingLife
P4Y9M18D
CY2022Q2 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1217715
CY2022Q2 eyen Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
2.69
eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P3Y2M12D
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6087845
eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P3Y2M12D
CY2022Q2 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1217715
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1870130
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
18701
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2019Q2 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2019Q2 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.04
CY2022Q2 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
47883
CY2021Q2 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
46663

Files In Submission

Name View Source Status
0001410578-22-002278-index-headers.html Edgar Link pending
0001410578-22-002278-index.html Edgar Link pending
eyen-20220630_cal.xml Edgar Link unprocessable
0001410578-22-002278.txt Edgar Link pending
0001410578-22-002278-xbrl.zip Edgar Link pending
eyen-20220630.xsd Edgar Link pending
eyen-20220630x10q.htm Edgar Link pending
eyen-20220630xex10d2.htm Edgar Link pending
eyen-20220630xex10d3.htm Edgar Link pending
eyen-20220630xex10d4.htm Edgar Link pending
eyen-20220630xex31d1.htm Edgar Link pending
eyen-20220630xex31d2.htm Edgar Link pending
eyen-20220630xex32d1.htm Edgar Link pending
eyen-20220630xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
eyen-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
eyen-20220630_lab.xml Edgar Link unprocessable
eyen-20220630_pre.xml Edgar Link unprocessable
eyen-20220630x10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending